NEW YORK STATE COMMON RETIREMENT FUND - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$1,267
+68.0%
48,046
+9.6%
0.00%
+100.0%
Q2 2023$754
-18.2%
43,849
-21.2%
0.00%0.0%
Q1 2023$922
+67.3%
55,612
-23.1%
0.00%0.0%
Q4 2022$551
-99.9%
72,286
-0.0%
0.00%0.0%
Q3 2022$719,000
+9.6%
72,312
+0.1%
0.00%0.0%
Q2 2022$656,000
-10.6%
72,215
-0.1%
0.00%0.0%
Q1 2022$734,000
-75.8%
72,299
-60.2%
0.00%
-66.7%
Q4 2021$3,030,000
-60.4%
181,647
+11.2%
0.00%
-62.5%
Q3 2021$7,656,000
-57.6%
163,352
-44.8%
0.01%
-57.9%
Q2 2021$18,049,000
+4.6%
296,079
+5.7%
0.02%0.0%
Q1 2021$17,263,000
+20.4%
280,245
+38.9%
0.02%
+18.8%
Q4 2020$14,342,000
+382.2%
201,689
+154.5%
0.02%
+300.0%
Q3 2020$2,974,000
+15.0%
79,2560.0%0.00%
+33.3%
Q2 2020$2,585,000
+57.0%
79,256
+39.5%
0.00%
+50.0%
Q1 2020$1,647,000
+135.0%
56,800
+184.0%
0.00%
+100.0%
Q4 2019$701,000
+84.5%
20,000
+13.0%
0.00%
Q3 2019$380,00017,7000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders